Literature DB >> 28840437

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Colorectal Cancer: Potential use of Perioperative Desmopressin to Reduce Allogenic Blood Transfusion Rates.

Juan Garona1,2, Natasha T Sobol1, Daniel F Alonso3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28840437     DOI： 10.1007/s11605-017-3551-6

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  17 in total

1.  Effects of the synthetic vasopressin analog desmopressin in a mouse model of colon cancer.

Authors:  Giselle V Ripoll; Juan Garona; Guillermo A Hermo; Daniel E Gomez; Daniel F Alonso
Journal:  Anticancer Res       Date:  2010-12       Impact factor: 2.480

2.  Endothelial von Willebrand factor regulates angiogenesis.

Authors:  Richard D Starke; Francesco Ferraro; Koralia E Paschalaki; Nicola H Dryden; Thomas A J McKinnon; Rachel E Sutton; Elspeth M Payne; Dorian O Haskard; Alun D Hughes; Daniel F Cutler; Mike A Laffan; Anna M Randi
Journal:  Blood       Date:  2010-11-03       Impact factor: 22.113

3.  Effectiveness of early and aggressive administration of fresh frozen plasma to reduce massive blood transfusion during cytoreductive surgery.

Authors:  Akshat Saxena; Terence C Chua; Salwan Fransi; Winston Liauw; David L Morris
Journal:  J Gastrointest Oncol       Date:  2013-03

4.  Insight into the effect of the vasopressin analog desmopressin on lung colonization by mammary carcinoma cells in BALB/c mice.

Authors:  Juan Garona; Marina Pifano; Alejandra M Scursoni; Daniel E Gomez; Daniel F Alonso; Giselle V Ripoll
Journal:  Anticancer Res       Date:  2014-09       Impact factor: 2.480

5.  Impact of perioperative blood transfusion on immune function and prognosis in colorectal cancer patients.

Authors:  Li Qiu; Dao-Rong Wang; Xiang-Yun Zhang; Shan Gao; Xiao-Xia Li; Gong-Ping Sun; Xiao-Bo Lu
Journal:  Transfus Apher Sci       Date:  2015-07-20       Impact factor: 1.764

Review 6.  The impact of perioperative red blood cell transfusions in patients undergoing liver resection: a systematic review.

Authors:  Sean Bennett; Laura K Baker; Guillaume Martel; Risa Shorr; Timothy M Pawlik; Alan Tinmouth; Daniel I McIsaac; Paul C Hébert; Paul J Karanicolas; Lauralyn McIntyre; Alexis F Turgeon; Jeffrey Barkun; Dean Fergusson
Journal:  HPB (Oxford)       Date:  2017-02-01       Impact factor: 3.647

7.  A protocol for management of blood loss in surgical treatment of peritoneal malignancy by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Authors:  N Sargant; A Roy; S Simpson; K Chandrakumaran; S Alves; J Coakes; J Bell; J Knight; P Wilson; F Mohamed; T Cecil; B Moran
Journal:  Transfus Med       Date:  2016-03-31       Impact factor: 2.019

8.  Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model.

Authors:  Giselle V Ripoll; Juan Garona; Marina Pifano; Hernan G Farina; Daniel E Gomez; Daniel F Alonso
Journal:  Breast Cancer Res Treat       Date:  2013-11       Impact factor: 4.872

9.  Factor VIII Is Synthesized in Human Endothelial Cells, Packaged in Weibel-Palade Bodies and Secreted Bound to ULVWF Strings.

Authors:  Nancy A Turner; Joel L Moake
Journal:  PLoS One       Date:  2015-10-16       Impact factor: 3.240

Review 10.  The Role of von Willebrand Factor in Vascular Inflammation: From Pathogenesis to Targeted Therapy.

Authors:  Felice Gragnano; Simona Sperlongano; Enrica Golia; Francesco Natale; Renatomaria Bianchi; Mario Crisci; Fabio Fimiani; Ivana Pariggiano; Vincenzo Diana; Andreina Carbone; Arturo Cesaro; Claudia Concilio; Giuseppe Limongelli; Mariagiovanna Russo; Paolo Calabrò
Journal:  Mediators Inflamm       Date:  2017-05-28       Impact factor: 4.711
View more
  1 in total

1.  Desmopressin acetate decreases blood loss in patients with massive hemorrhage undergoing gastrointestinal surgery.

Authors:  Li-Chun Wang; Ying-Fang Hu; Lei Chen; Rui Xing; Xin-Feng Lin; Qiu-Ye Kou
Journal:  Turk J Gastroenterol       Date:  2020-06       Impact factor: 1.852
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.